Media Centre
© Enthera. All rights reserved
Enthera Srl
Corporate Headquarters: Via Borgogna, 5, 20122 Milan Italy
Registered office: Via Visconti di Modrone Uberto, 18, 20122 Milan Italy
Phone: +39 02 49533580
Email: info@entherapharmaceuticals.com
Enthera Srl
Corporate Headquarters: Via Borgogna, 5, 20122 Milan Italy
Registered office: Via Visconti di Modrone Uberto, 18, 20122 Milan Italy
Phone: +39 02 49533580
Email: info@entherapharmaceuticals.com
This website uses only technical cookies and does not perform any profiling or collection of personal data through cookies. Simply browsing the website does not require the user’s consent.
Website by Instinctif Partners
Enthera Pharmaceuticals opens early drug discovery unit at OpenZone life sciences campus to expand autoimmune disease research
/in Press ReleasesThe OpenZone drug discovery unit will be used to support Enthera’s new discovery program and accelerate its mission to identify new treatments for intractable autoimmune diseases Milan, Italy, 7 July 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel apoptosis pathway, today […]
Enthera Pharmaceuticals Appoints Claudia Nardini as Vice President of Research and Development
/in Press ReleasesMilan, Italy, 1 April 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing novel disease-modifying biologics that re-establish stem cell capabilities to treat specific autoimmune diseases, today announces the appointment of Claudia Nardini as Vice President of Research and Development to support the Company’s manufacturing and regulatory divisions. Claudia has 25 years of experience in […]
Enthera Pharmaceuticals extends Series A financing, raising a total of €35 million
/in Press ReleasesThe Roche Venture Fund joins international investor syndicate, including co-lead investors Sofinnova Partners and AbbVie Ventures Funds to be used to advance restorative therapy for type 1 diabetes and inflammatory bowel disease Largest international VC-backed Series A financing round for a biotech in Italy to date and first ever venture investment in an Italian company […]